U-Blot® Research Grade RosnilimabCat. No. WA3484Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade RosnilimabCat. No. WA3484U-Blot® Research Grade RosmantuzumabCat. No. WA3483Request quote
Size: 50ug/100ug
U-Blot® Research Grade RontalizumabCat. No. WA3482Request quote
Size: 50ug/100ug
U-Blot® Research Grade RomosozumabCat. No. WA3481Request quote
Size: 50ug/100ug
U-Blot® Research Grade RomlusevimabCat. No. WA3480Request quote
Size: 50ug/100ug
U-Blot® Research Grade RomilkimabCat. No. WA3479Request quote
Size: 50ug/100ug
U-Blot® Research Grade roltotatugCat. No. WA3478Request quote
Size: 50ug/100ug
U-Blot® Research Grade RolistobartCat. No. WA3477Request quote
Size: 50ug/100ug
U-Blot® Research Grade RolinsatamabCat. No. WA3476Request quote
Size: 50ug/100ug
U-Blot® Research Grade RoledumabCat. No. WA3475Request quote
Size: 50ug/100ug
U-Blot® Research Grade rolditamigCat. No. WA3474Request quote
Size: 50ug/100ug
U-Blot® Research Grade RoconkibartCat. No. WA3473Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598